Dina DiCenso

Keine laufenden Positionen mehr

Finance

Consumer Services

Profil

Prior to joining Epoch, Dr. DiCenso was an associate at Finnerty Economic Consulting where she specialized in statistical analysis of financial and economic data.
She is currently an Adjunct Professor at Fordham University where she is teaching managerial and macro-economics classes.
Dr. DiCenso was an economic and policy research analyst at Pfizer, and held various positions at Zurich Scudder Investments and Liberty Mutual Funds.
Dr. DiCenso earned a Ph.D.
in Economics from Fordham University, an MSF from Northeastern University, and a BA in Philosophy and Classics from the University of Arizona.

Ehemalige bekannte Positionen von Dina DiCenso

Unternehmen	Position	Ende
Pfizer Venture Investments LLC Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor.	Corporate Officer/Principal	30.07.2004
Zurich Scudder Investments, Inc. Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services	Corporate Officer/Principal	30.04.2001
Partners First Partners First Finance/Rental/LeasingFinance Provides credit cards and services	Corporate Officer/Principal	31.12.1999
Epoch Investment Partners, Inc. Epoch Investment Partners, Inc. Investment ManagersFinance TD Epoch’s investment approach for equity strategies is based on bottom-up, fundamental research, seeking companies that can grow free cash flow and allocate it intelligently for the benefit of shareholders or have superior earnings growth. Their approach to portfolio construction for fixed income strategies is disciplined and focuses on sector allocation, yield curve analysis and credit quality.	Analyst-Equity	-

Sehen Sie sich die Erfahrung von Dina DiCenso im Detail an

Ausbildung von Dina DiCenso

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Dina DiCenso im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
Zurich Scudder Investments, Inc. Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services	Finance
Partners First Partners First Finance/Rental/LeasingFinance Provides credit cards and services	Finance
Epoch Investment Partners, Inc. Epoch Investment Partners, Inc. Investment ManagersFinance TD Epoch’s investment approach for equity strategies is based on bottom-up, fundamental research, seeking companies that can grow free cash flow and allocate it intelligently for the benefit of shareholders or have superior earnings growth. Their approach to portfolio construction for fixed income strategies is disciplined and focuses on sector allocation, yield curve analysis and credit quality.	Finance
Fordham University Fordham University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northeastern University Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Arizona University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pfizer Venture Investments LLC Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor.	Finance